Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Lilema medical in Sweden AB
AB
Active
Org 5591999692
Hagalundsgatan 21, 169 66
Solna
Retail sale of pharmaceutical products
· NACE 4773
Est. 2019
2 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Lilema medical in Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
3M
7M
10M
14M
4M
2021
9M
2022
8M
2023
10M
2024
12M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
1M
2023
1M
2024
1M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
3 604
9 280
8 144
9 688
11 699
Staff expenses
—
−1 591
—
—
−1 159
EBITDA
96
339
562
625
1 036
Depreciation & amort.
−65
−110
−112
−128
−128
EBIT
31
229
450
497
908
Net financials
−1
−4
—
−1
0
Profit before tax
30
225
451
495
683
Tax
−7
−47
−94
−104
−141
Net profit
23
178
357
391
542
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
2 956
3 656
2 870
3 563
3 563
Equity
71
249
606
997
1 539
Long-term debt
0
—
0
0
—
Short-term debt
2 885
3 407
2 264
2 566
1 799
Total debt
2 885
3 407
2 264
2 566
1 799
Financial ratios
5-year trend
EBITDA margin
8.9%
This company
15.8%
Market median
-44% vs market
2021
2025
Equity ratio
43.2%
This company
38.2%
Market median
+13% vs market
2021
2025
Return on equity
35.2%
This company
18.4%
Market median
+91% vs market
2021
2025
Net profit margin
4.6%
This company
8.1%
Market median
-43% vs market
2021
2025
Asset turnover
3.28×
This company
1.12×
Market median
+193% vs market
2021
2025
Debt / equity
1.32×
This company
0.62×
Market median
-113% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
View
PDF
More on Lilema medical in Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
